A carregar...

Targeting of the Diabetes Prevention Program leads to substantial benefits when capacity is constrained

OBJECTIVE: Approximately 84 million people in the US have pre-diabetes, but only a fraction of them receive proven effective therapies to prevent type 2 diabetes. We estimated the value of prioritizing individuals at highest risk of progression to diabetes for treatment, compared to non-targeted tre...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Acta Diabetol
Main Authors: Olchanski, Natalia, van Klaveren, David, Cohen, Joshua T., Wong, John B., Ruthazer, Robin, Kent, David M.
Formato: Artigo
Idioma:Inglês
Publicado em: 2021
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8276501/
https://ncbi.nlm.nih.gov/pubmed/33517494
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00592-021-01672-3
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!